TIP_link_300x300.jpg
Molecular Biology Enzymes, Kits, and Reagents Market Worth $41.10Bn, Globally, by 2028 at 17.8% CAGR Lead by Kits & Reagents Segment: The Insight Partners
26 mai 2022 02h31 HE | The Insight Partners
New York, May 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 – COVID-19 Impact and Global...
Synlogic_Logo_Blue.png
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria
24 mai 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic_Logo_Blue.png
Synlogic Announces First Quarter 2022 Conference Call and Webcast
05 mai 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic_Logo_Blue.png
Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium
28 avr. 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic_Logo_Blue.png
Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
26 avr. 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
logo_Codex_landscape_color_RGB (1).png
Codex DNA to Showcase Innovative SOLA Enzymatic DNA Synthesis Technology and Automated Benchtop BioXp System at SynBioBeta’s Built with Biology Global Conference
06 avr. 2022 08h03 HE | Codex DNA, Inc.
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) --  Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker lineup for presentations at...
Synlogic Logo (no background).png
Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting
01 avr. 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synthetic Biology Global Market Forecasts to 2026: Focus on Value-Added Products and New Technology Developments Driving Innovation
17 mars 2022 08h58 HE | Research and Markets
Dublin, March 17, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Global Market" report has been added to ResearchAndMarkets.com's offering. The synthetic biology industry is a prime growth...
Synlogic Logo (no background).png
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
17 mars 2022 07h00 HE | Synlogic, Inc.
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in H2 2022 – - Clinical readouts anticipated for PKU program in H1 2022 and in homocystinuria and enteric hyperoxaluria in H2...
22157.jpg
Outlook on the Synthetic Biology: Protein Design and Engineering Global Market to 2035 - Industry Trends and Forecasts
16 mars 2022 07h48 HE | Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of...